Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
749 hedge funds and large institutions have $48.9B invested in Allergan Inc in 2014 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 217 increasing their positions, 362 reducing their positions, and 81 closing their positions.
4% more capital invested
Capital invested by funds: $47B → $48.9B (+$1.87B)
3% less funds holding
Funds holding: 770 → 749 (-21)
14% less funds holding in top 10
Funds holding in top 10: 74 → 64 (-10)
16% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 81
40% less repeat investments, than reductions
Existing positions increased: 217 | Existing positions reduced: 362
47% less call options, than puts
Call options by funds: $851M | Put options by funds: $1.61B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$474M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$382M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$294M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$245M |
| 5 |
SC
Sculptor Capital
New York
|
+$218M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$361M |
| 2 |
PC
Perry Capital
New York
|
-$282M |
| 3 |
YCMGA
York Capital Management Global Advisors
New York
|
-$237M |
| 4 |
VAM
Visium Asset Management
New York
|
-$234M |
| 5 |
MCM
Mason Capital Management
New York
|
-$209M |
AGN Hedge Fund Activity: Q3 2014 in Review
749 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q3 2014, worth a combined $48.9B — up 4% from $47B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of AGN and 68 opened new positions — a net loss of 13 holders — while 362 trimmed existing stakes and 217 added.
The largest buyer was Fidelity Investments, adding an estimated $474M. The largest seller was Norges Bank, cutting an estimated $361M.
- 749 institutional investors held Allergan Inc (AGN) as of Q3 2014, down from 770 in Q2 2014.
- Funds reported $48.9B of Allergan Inc stock for Q3 2014, up 4% quarter-over-quarter.
- 68 funds opened new Allergan Inc positions in Q3 2014 and 81 closed out, a net change of -13 holders.
- The largest Allergan Inc buyer in Q3 2014 was Fidelity Investments, an estimated $474M added.
- The largest Allergan Inc seller in Q3 2014 was Norges Bank, an estimated $361M sold.
Based on aggregated 13F filings for Q3 2014.